Breaking AI & Tech News Analyzed

The LeadA daily pill has shown remarkable results in doubling survival time for patients with pancreatic cancer, the world's deadliest form of the disease. According to clinical trial results presented at the American Society of Clinical Oncology's annual meeting, this breakthrough treatment represents a potential revolution in how we approach a cancer that has seen limited progress for decades.The Breakthrough Drug: DaraxonrasibThe drug in question, daraxonrasib, works by targeting a protein called Kras that fuels nearly all pancreatic cancers. This mechanism represents a significant advancement in treatment strategy, as Kras has been notoriously difficult to target effectively. The drug functions as a Ras(On) multi-selective inhibitor, capable of turning off the Kras protein to stop cancer growth regardless of which variant is present.Impressive Trial ResultsIn the clinical trial involving 500 patients with advanced pancreatic cancer, the results were striking. Those who took daraxonrasib lived an average of 13.2 months, compared to just 6.6 to 6.7 months for patients who received chemotherapy. This represents a near doubling of survival time, with the added benefit of fewer side effects compared to traditional chemotherapy treatments.Industry Impact and Expert ReactionsThe findings have been hailed as a "gamechanger" and "grand slam" by experts in the field. Dr. Rachna Shroff, chief of oncology at the University of Arizona Cancer Center, described the results as "landscape-changing" and "unprecedented survival." When she first read the trial results, conducted by researchers at the Dana-Farber Cancer Institute in Boston, she wept, noting the profound impact this could have on patients after 16 years of treating pancreatic cancer.Dr. Julie Gralow, Asco's chief medical officer, echoed these sentiments, calling the study a "home run" and suggesting it was actually a "grand slam" in terms of its significance.The Ras RevolutionOver 90% of patients with the most common form of pancreatic cancer, pancreatic ductal adenocarcinoma (mPDAC), have a mutation in the Kras gene. This discovery has long been considered the "holy grail" in cancer research, particularly for pancreatic cancer where the mutation is nearly ubiquitous and an early driver of cancer growth.Paula Hanford, chief executive of UK-based Pancreatic Cancer Action, called this one of the most significant developments in treatment she had ever seen. Similarly, Anna Jewell, director of services, research and innovation at Pancreatic Cancer UK, described the results as "exciting," noting that the drug gives patients "months more precious time with their loved ones."Future Outlook and ApplicationsThe success of daraxonrasib opens doors for similar treatments targeting Ras genes in other cancers. Experts at the conference noted that because Ras genes fuel various types of cancer, there is hope for breakthroughs in treating lung and colon cancers as well, with similar drugs already in development for these conditions.However, challenges remain in ensuring these promising treatments become widely available to patients. As Jewell pointed out, tragically half of all people with pancreatic cancer die within just three months of diagnosis, making the rapid implementation of such treatments crucial.

Iga Swiatek's Unhappy Birthday at French Open Iga Swiatek's 25th birthday celebrations turned sour at the French Open on Sunday as the former champion lost 7-5, 6-1 in the fourth round to the Ukrainian 15th seed Marta Kostyuk, her challenge for a fifth title ending just when she had looked to be rediscovering her rhythm. The Match Turning Point There was little to separate the duo in the early exchanges as they twice traded breaks, before Kostyuk came up with a tight hold in the 11th game and raised her level at the end to claim the opening set with a backhand crosscourt winner. Kostyuk's Historic Win It was the first time that Kostyuk had taken a set off the third-seeded Pole after three straight-set defeats in their previous meetings, and she sensed a big upset when she went ahead 3-1 in the next set after a battling effort. The Impact on Swiatek's Title Hopes The Rouen and Madrid champion held her nerve from there to take her record on clay this season to 15-0, and book a meeting with the seventh-seeded Ukrainian Elina Svitolina or the 11th-seeded Swiss Belinda Bencic in the next round at Roland Garros. What's Next Tumaini Carayol’s report to follow

Uncovering Family History Through Fiction Maggie O'Farrell's journey into her family's past began with a childhood myth about an ancestor who worked on the first maps of Ireland. Years later, a hand-drawn map and an old photograph led her to discover the truth about her great-great-grandfather's role in the Ordnance Survey. The Mapper's Story O'Farrell's ancestor was a labourer and translator who worked on mapping divisions in Ireland during the aftermath of the great famine. His task was to ensure that the changes caused by the disaster were marked on the new post-famine versions of Ireland's maps. A Window into the Past The photograph showed O'Farrell's great-great-grandfather with a child on his knee, wearing a worn jacket and a low-brimmed hat. A hand-drawn map, beautifully rendered in coloured inks, revealed a tiny medallion with a red-jacketed soldier and O'Farrell's ancestor. The discovery sparked O'Farrell's curiosity about her family's history and the history of Ireland. The Impact of the Great Famine The great famine, which occurred between 1846 and 1852, had a devastating impact on Ireland, with over a million people dying of starvation or famine-related disease, and another million forced to emigrate. Fiction as a Tool for Discovery O'Farrell believes that fiction comes from what you don't know, and her book 'Land' is a testament to this. The novel tells the story of a man, Tomás, and his family, striving to emerge from the long shadow of the great famine. A New Perspective O'Farrell's book offers a new perspective on the history of Ireland and the impact of the great famine on families. Her research and writing have shed light on a little-known aspect of her family's history and the history of Ireland.

Sky announced it will exit its 24‑hour Arabic news joint venture with the United Arab Emirates, Sky News Arabia, following intense criticism over the channel’s coverage of the Sudan war and accusations of genocide denial. Under a new commercial agreement, Sky will give up all strategic and operational control but will continue to license the Sky News brand to the outlet. Strategic Withdrawal and New Licensing Arrangement The exit sees Sky handing over full ownership to IMI, the investment vehicle controlled by Sheikh Mansour bin Zayed al‑Nahyan, UAE vice‑president and Manchester City owner. In a statement, David Rhodes, executive chairman of Sky News Group, said the partnership had built a significant regional presence and that the timing was right for a change. IMI will now steer the platform’s future, while Sky secures a multi‑year brand‑licensing deal that lets the channel retain the Sky News Arabia name. Timeline of Sky News Arabia’s Decade‑Long Presence 2010: Channel launched in Abu Dhabi as a rival to Al‑Jazeera and BBC Arabic. 2012: Joint venture began broadcasting across the Middle East and North Africa. November 2025: Sudanese government banned the channel after a report claimed stability in El Fasher. February 2026: UN fact‑finding mission identified “hallmarks of genocide” in the RSF siege of El Fasher. May 2026: Sky announces exit and new licensing deal. Reputational and Regional Implications of the Sudan Coverage Controversy Internal Sky executives grew uneasy about the editorial line taken by Sky News Arabia, which was accused of whitewashing atrocities committed by the UAE‑backed Rapid Support Forces (RSF). Specific concerns included a report that downplayed the humanitarian crisis and the fact that the channel’s reporter in El Fasher was married to a senior RSF official. The controversy prompted Sudan to ban the channel and heightened scrutiny of the venture’s credibility across the Arab world. Future Outlook for Sky’s Middle‑East Footprint Nakhle ElHage, chief transformation officer at IMI, said the next phase will focus on building the platform into the leading multi‑media news destination for the Arab world. For Sky, the move mirrors a similar decision in Australia, where a licensing agreement for the Sky News brand is ending and the channel will rebrand as News24. The brand‑licensing arrangement allows Sky to maintain a presence without direct editorial responsibility, while IMI gains full control to shape content and investment strategy.

The Lead: Liverpool at a CrossroadsAs Liverpool prepares for life after Arne Slot, the club faces significant challenges that will define their immediate future. The Dutchman's tenure ended without the dominance expected, leaving a squad in need of strategic overhaul both on and off the pitch. The new manager inherits a team that must rediscover its identity while addressing key personnel departures and tactical shortcomings.Style Evolution: From Heavy Metal to Soft RockPerhaps Mohamed Salah's style of communication wasn't the slickest, but he was correct that Liverpool need to redefine the style of football they play. Everything on the pitch last season under Arne Slot felt very placid as Liverpool failed to dominate opponents and were often found overrun. The new head coach will want to demonstrate his plans and implement an attacking style to best use what is available to him. Anfield does not want to witness back-foot football, fans want to see a swagger to those in red. Supporters and Slot suffered from a disconnect in the final months. The Dutchman was hindered by not possessing the vivacious personality of Jürgen Klopp nor the results in the end, and the aforementioned tedious style. The successor will want to put fans at the forefront and build a strong bond between stands and dugout, built on a platform of attractive play.Investment Analysis: Underperforming Key SigningsAfter spending heavily last summer trying to build a squad capable of dominating the Premier League for years to come, it was difficult to pick out someone who thrived. Hugo Ekitiké was the best of the new arrivals but record signings Florian Wirtz and Alexander Isak barely made the season's footnotes. Isak could at least attribute his struggles to fitness and injury problems, including a leg fracture, but the German's first taste of English football was a sour one. He never looked comfortable as a No 10, physically finding it tough going as speed on the ball and strength in battle were lacking. Getting the best out of a clearly talented player must be a priority, because Wirtz has the capabilities to open defences and help Liverpool control games but needs a confidence boost and an arm around the shoulder.Structural Impact: Midfield Deficiencies and Leadership VacuumWirtz is part of a wider midfield issue that lacks physicality and an obvious No 6. Ryan Gravenberch was elected as the man for the role by Slot, which worked well when the possession stats were in Liverpool's favour but finding someone who can break things up effectively is advisable. Every other team have someone who can break up play but Liverpool lack someone in that role. Not since Georginio Wijnaldum or Fabinho have the club possessed someone capable of overwhelming opponents with their physical attributes and in an evolving sport, this oversight must end. Dominik Szoboszlai being moved around the pitch was unhelpful because he can be one of the best central midfielders in the world but needs a defined position to make his own.The players departing Anfield are weighed down with individual and team trinkets, thanks to the success they have enjoyed with Liverpool. Arguably, the influence of Salah and Andy Robertson on the pitch waned in their final season with the club but their experience and winning mentality will be a huge loss to the dressing room and training ground. Ibrahima Konaté is another exiting, providing a recruitment headache the club were not fully anticipating. It does beg the question if it is the right time to allow Alisson Becker, who has suffered from injury problems in recent times, to be sold and allow a new generation to start afresh, with Virgil van Dijk leading the transition. There are plenty of potential internal candidates who can take on greater responsibility but it may require a change in transfer strategy to acquire players in their late-20s with Champions League experience to help give the right balance.Defensive Rebuild: Addressing Key DeparturesKonaté's contract expiration will be softened by Jérémy Jacquet's impending arrival but further investment is required. Van Dijk's longevity is unknown so finding a partnership for the long term will be critical; a more rugged centre-back like Nottingham Forest's Murillo could be an ideal choice to offer balance and greater aggression. Competition for Milos Kerkez will be important, but if Andoni Iraola does take the job the reunion could get the best out of the Hungarian and get him to flourish after a mixed first year on Merseyside. On the opposite side, continuity would help everyone because Slot was forced to trying numerous people in the role, many out of position. Ideally, Conor Bradley or Jeremie Frimpong can make it their own, having struggled to replace Trent Alexander-Arnold, although both have suffered with injury problems. If they can stay fit, they both possess the quality to be a solution, especially if clever coaching can embrace their attacking prowess and incorporate more defensive discipline.Future Outlook: Rebuilding the AttackSlot insisted that new wingers would change the dynamic next season but he will not be the one to benefit. Salah is off, Federico Chiesa cannot carry on as a bit-part, so will almost certainly leave too, freeing up some space on the flanks. Rio Ngumoha offered brief teenage glimpses of excitement as someone with the pace and trickery to get past full-backs. Frimpong, brought in as a right-back, was more often found on the wing because he possessed the speed Slot desired in those areas, while also offering a further indication that the transfer dealings left a lot to be desired. They did not replace the maverick tendencies of Luis Díaz and Cody Gakpo has never looked a natural winger. Targeting new wide men will be imperative. RB Leipzig's Yan Diomande, Brighton's Yankuba Minteh or Athletic Club's Neco Williams would be ideal candidates to bring thrust to a side lacking dynamism and get supporters off their seats.

The Connection to Nature As a recent study revealed almost half of UK adults now spend less than three hours a week in natural settings such as gardens, parks, fields or woods, we asked readers to tell us about what being outside means to them. Personal Stories of Healing The replies – heartfelt and passionate – came flooding in, with some admitting they just did not have the words to say how important it is. “It’s my happy place, my therapy and a reason to slow down and pause during my busy week,” wrote Hannah Powell from Perrywood garden centres. “I HAVE to look at plants every day. I notice every change in the garden. I sit facing the garden for my breakfast. I look out for nature on the way to work (recently seeing a little owl, red kites, foxes, hares, and more). It helped me get better when I had burnout and FND in London. I wouldn’t (couldn’t) be without it.” The Science Behind Nature's Benefits David Lynch esaid about his love of being outside. “Anxiety levels drop, all worldly concerns are put in perspective and [I] feel younger.” He agreed with others that there was plenty of recent science explaining the health benefits, but added: “I also read about ancient wisdom of Buddhism, which advocates solitary time in nature. All sources uphold the truth that better connection with nature brings better self-awareness and increased sensitivity to the needs of our ecosystem, plus better connection with each other.” The Impact on Mental Health Isabel Romaniw, who is working towards becoming a forest bathing guide, wrote passionately about the basic human need to be outside and to connect with nature. “We are animal, a simultaneously ordinary and yet utterly remarkable part of the great, miraculous tapestry of life on Earth. We have done much to shape our world and influence the fates of almost all other species we share our world with, but we must remember that we are but a tiny chapter, perhaps a footnote, in the ongoing story of the universe, in order to start to heal the damage and repair our relationships with ourselves, with each other, with our other-than-human kin, and with our one precious home.” For Romaniw, as for many others, our disconnection with nature is closely linked to “the worsening physical, mental and spiritual health crises that seem to be going on”. Cherished Memories of Nature Many of you had wonderful memories of times outside. “I was a sickly, pasty, shy, anxious kid,” wrote Mat Jordan. “In the early 70s my parents couldn’t afford to take us to the seaside one year so we went camping in the Peak District instead. It was a revelation. I absolutely loved it. The landscape and dry-stone walls of the white peak are still a favourite, although I spent some years in my 20s living in the Lake District too. One of my favourite memories is driving out of Sheffield into the Peaks with my then baby son to get him to fall asleep and still being awe-struck at the beauty on our doorstep.”

Executive Summary: Trump Sends Revised Iran Deal FrameworkPresident Donald Trump has returned a new proposal to Iran that tightens several conditions of a deal intended to end the ongoing US‑Israel war on Iran. Media outlets including The New York Times and Axios say the revisions emphasize stricter controls on Iran’s nuclear material and the reopening of the strategic Strait of Hormuz.Revised Deal Terms Emphasize Nuclear Material Controls and Hormuz AccessThe updated framework, described as a “toughening” of the original terms, was sent back to Tehran after a White House Situation Room meeting on May 30, 2026. While the exact language of the changes was not disclosed, officials note that Trump wants to reinforce points he deems critical, such as:Ensuring Iran never develops nuclear weapons.Reopening the blockaded Strait of Hormuz, a key oil transit route.Clarifying procedures for handling Iran’s existing nuclear material.A senior U.S. official warned that Iran could need up to three days to formulate a response, noting the logistical challenges faced by Iranian negotiators.Quantitative Context: Oil Flow Through Strait of Hormuz and Timeline Estimates20 % of the world’s oil supply transits the Strait of Hormuz, making its reopening a high‑stakes demand.Iranian officials indicated a response window of three days, though U.S. officials suggested the overall process could extend from a few days to a week or more.The war began after the U.S. and Israel attacked Iran on February 28, 2026, and no final deal has been signed to date.Geopolitical Ramifications for US‑Israel‑Iran RelationsThe tightened terms could lengthen negotiations, potentially delaying any cessation of hostilities. Iran’s military headquarters has reiterated control over the Strait, warning that non‑compliant vessels may be targeted, which raises the risk of broader maritime confrontations. Meanwhile, U.S. officials remain publicly committed to a deal that prevents nuclear weapon development while safeguarding global oil flows.Outlook: Potential Scenarios for Deal FinalizationIf Iran accepts the revised framework within the projected response window, a cease‑fire could be announced within a week, easing regional tensions.Should negotiations stall, the war could continue, with heightened naval activity in the Strait of Hormuz affecting global oil markets.Extended delays may prompt the U.S. to reconsider its diplomatic approach, possibly escalating military posturing or seeking alternative multilateral pressure on Tehran.

The Lead: Unprecedented Cancer Treatment SuccessDoctors have hailed "unprecedented" trial results that show a triple-action cancer jab can eradicate entire tumours in patients. In an international trial spanning 11 countries, the injection was offered to patients whose cancer had spread or come back and whose disease had failed to respond to other treatments.The Breakthrough: Amivantamab's Triple-Action ApproachThe jab, called amivantamab, shrank the tumours of more than a third of patients, with dramatic changes seen within weeks. In 15 of them, doctors found the drug had melted away their tumours altogether.The smart jab targets cancer in three ways. It blocks both EGFR (epidermal growth factor receptor), a protein that helps tumours grow, and MET, a pathway that cancer cells often use to escape treatment. It also helps activate the immune system to attack the tumour.The Clinical Trial Data: Impressive Response RatesIn the trial, 102 patients with head and neck cancer, the world's sixth most common cancer, were given the jab. Tumours shrank or disappeared completely in 43 patients, including 28 whose tumours shrank significantly and 15 who saw them eradicated entirely.Patients receiving amivantamab lived for a median of 12.5 months overall after starting treatment, despite having a form of cancer with very poor outcomes, once standard treatments stop working.The Impact Analysis: New Hope for Treatment-Resistant CancersKevin Harrington, professor in biological cancer therapies at the Institute of Cancer Research, London (ICR), said: "These are unprecedentedly strong responses in patients whose disease has become resistant to both chemotherapy and immunotherapy. This is a group of patients for whom treatment options are extremely limited, so seeing this level of benefit is very striking."Researchers also highlighted that the trial focused on people with head and neck cancers that did not include those with human papillomavirus (HPV) positive oropharyngeal squamous cell carcinoma. That is particularly significant, they said, since head and neck cancers not caused by HPV are usually harder to treat, making progress in this group hugely important.The Patient Experience: Transforming Quality of LifeOne of the first patients to benefit was Carl Walsh, 56, who was diagnosed with tongue cancer in May 2024 and joined the OrigAMI-4 trial at the Royal Marsden in July 2025. "I was initially treated with both chemotherapy and immunotherapy, which unfortunately were not successful," he said. "At that point, I was recommended for the OrigAMI-4 trial. I'm now on my 17th cycle of treatment and I'm very pleased with the progress so far."Unlike many cancer treatments, amivantamab is given as a tiny jab under the skin rather than via an intravenous drip, making treatment quicker and more convenient for patients and much easier to deliver in outpatient clinics.The Future Outlook: Expanding Treatment ApplicationsThe results will be presented on Sunday in Chicago at the world's largest cancer conference, the annual meeting of the American Society of Clinical Oncology (Asco).Amivantamab, developed by Johnson & Johnson, is now being evaluated in about 60 clinical trials, primarily for lung cancer, but also for colorectal, brain and gastric cancers.Prof Kristian Helin, the chief executive of the ICR, said: "This study demonstrates how the development of new treatments through rigorous cancer research may lead to meaningful advances, even for patients with very limited treatment options. Achieving this level of tumour response and encouraging survival outcomes in such a challenging-to-treat group represents a significant step forward."

The Cancellation of Kanye West's Concert in Italy Kanye West's concert in Italy has been cancelled over 'public order and safety issues'. The 48-year-old rapper, who changed his name to Ye in 2021, was due to perform at the Pulse of Gaia festival at the RCF Arena in Reggio Emilia on 18 July. Concerns Over Antisemitic Remarks The city's prefect, Salvatore Angieri, stopped the gigs after 'concerns' from the local Jewish community over previous antisemitic remarks by West. West has been criticized for his antisemitic comments, including a song called 'Heil Hitler in 2025' and advertising a swastika T-shirt for sale on his website. Impact on Travis Scott's Concert A concert on 17 July by West's fellow US rapper Travis Scott at Hellwatt festival has also been cancelled due to the two festivals being scheduled on consecutive days. Scott faced criticism after 10 people aged between nine and 27 died at his Astroworld festival in Houston, Texas, in 2021. Previous Cancellations and Apologies In April, West's show in Marseille, France, was postponed after he had been denied a UK visa earlier that month. That led to the cancellation of his headline appearances at London's Wireless festival, following backlash due to antisemitic remarks. West released a statement apologizing for his actions, stating 'I am not a Nazi or an antisemite. I love Jewish people.' Future Performances West will perform at Istanbul's Atatürk Olympic Stadium in Turkey on Saturday and is still due to perform at the GelreDome football stadium in Arnhem, the Netherlands, on 6 and 8 June.